Cochrane Handb Syst Reviews Interventions [Internet] 2024
In Vivo Assessment of Drug Interactions Effect of Sitagliptin on Other Drugs In clinical studies, as described below, sitagliptin did not meaningfully alter the pharmacokinetics of metformin, glyburide, simvastatin, rosiglitazone, warfarin, or oral contraceptives, providing in vivo evidence of a low propensity for causing drug interactions with substrates of CYP3A4, CYP2C8, CYP2C9, and organic cationic transporter (OCT)
Looking Ahead Next-generation molecules dual, triple, and quadruple agonists (GLP-1/GIP/GCGR/FGF21) are designed to deliver the Quatro Metabolic Effect: 1 Glycemic control 2 Weight reduction 3 Hepato-protection 4 Cardio-metabolic improvement These therapies may soon redefine our approach to NAFLD, NASH, and metabolic syndrome, not merely as treatments, but as metabolic regenerative therapies
Once it gains approval by the MHRA (medicines healthcare products regulatory agency), Quick Meds is expecting to offer this to all eligible patients
Your provider will review your current blood pressure medications, including propranolol, to ensure the combination is safe for your specific health profile
